Figure 1.
Schematic illustrations depicting (A) Synthesis of gardiquimod-loaded mesoporous silica coated polydopamine nanoparticles (gardi-mPDA) and NIR-assisted drug release. (B) Tumor ablation and drug release under NIR irradiation followed by activation of DCs and effector T cells in tumor draining lymph nodes for regression of primary and secondary tumors.